Antihistamine for Prevention of HTR After Blood Primed CPB

Clinical trial NCT07536152 · RECRUITING

Trial details

NCT number: NCT07536152
Sponsor: Kasr El Aini Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Blood Transfusion Associated Adverse Reactions

Start date: 2026-03-01
Primary completion: 2026-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.